Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IAT Institut für Angewandte Therapieforschung (IAT) is a German contract research organization (CRO) providing comprehensive clinical trial services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1993 and headquartered in Ulm-Hofen, the company specializes in the planning, coordination, and execution of Phase II through IV clinical trials, as well as non-interventional studies. Their service portfolio includes clinical monitoring, project management, data management, biostatistics, and medical writing. IAT is recognized for its regional expertise in Central Europe and its ability to manage complex regulatory requirements for clinical development. The company serves a diverse client base ranging from small biotech startups to large multinational pharmaceutical corporations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IAT Hofen Gruppe.